Skip to main content

Table 2 Product characteristics and average price levelsa

From: Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?

Product characteristic

Percent of products (N = 6,182)

Mean (SD) USD Price Level in 2013

Manufacturer Count per Product

 1

27%

92.90 (721.02)

 2

6%

23.47 (108.27)

 3

8%

16.13 (71.54)

 4

6%

8.79 (37.44)

 ≥ 5

53%

2.65 (16.94)

Formulation

 All Others

22%

41.23 (526.71)

 Injectable

14%

133.76 (753.03)

 Oral

64%

2.63 (14.24)

Patent Status

 Branded Generic

21%

112.03 (822.57)

 Generic

79%

8.36 (54.11)

Volume in previous period

 Very low volume (<1,000 units per quarter)

10%

142.14 (1,077.18)

 All other drugs

90%

17.65 (186.61)

Orphan Drug Designation

 No

92%

13.53 (78.45)

 Yes

8%

214.16 (1,293.70)

  1. aAuthors’ calculations using IQVIA Health NSP data. All analyses used STATA 14.0 (College Station, Texas)